Collaboration Inquiries
Latest News Press Release Recent Articles Current & Upcoming Meetings and Events Past Meetings and Events
Contact Information
VacciMax® Platform Advantage VacciMax® Proof of Concept VacciMax® Platform Scale-up
Board of Directors Corporate Profile In Memorium Scientific Advisors Senior Management Technical Advisors
Contact Us Partners Press Releases Spayvac Vaccimax Corporate Profile Home
  HOME | PROFILE | VACCIMAX® PLATFORM | PRESS | PARTNERS | CAREERS | CONTACT  


Delivering Breakthrough Vaccines

IVT’s goal is to generate sustainable, long-term revenues by developing and commercializing VacciMax® based vaccines through early clinical development, multiple partnerships and licensing agreements with major vaccine companies.

LATEST NEWS

Vaccine Development Aided by New Techniques

On The Move - ImmunoVaccine Technologis Inc. has been selected as one of Canada's Top 10 Life Sciences Companies

Vaccine breakthrough heralds new cancer treatment

ImmunoVaccine Technologies’ DepoVax™ Shows Positive Results for Cancer and Infectious Diseases

ImmunoVaccine Technologies selected as Canada's Top 10™ Life Sciences Companies

 

CONTACT INFORMATION

Corporate Offices

ImmunoVaccine Technologies Inc.
1819 Granville Street, Suite 303
Halifax, Nova Scotia, B3J 3R1
Tel (902) 492-1819

Fax (902) 492-0888

Email: info@immunovaccine.com

Research Facilitybutton-map

BioScience Enterprise Centre
1721 Lower Water Street
Halifax, NS, B3J 1S5
Tel (902) 492-1819
Fax (902) 492-0888

Investment Opportunities

Contact: Mr. Brian Lowe
Vice President
Email: bl.ivt@immunovaccine.com

Business Development Opportunities

Contact: Ms. Ella Korets-Smith

Director of Business Development
Email: eks.ivt@immunovaccine.com

 

For more information, please go to our Document Library www.deliveringbreakthroughs.com

  HOME | PROFILE | PRODUCT | PRESS | PARTNERS | CAREERS | CONTACT